CUTISS
Chiara Pagliuca is a skilled professional in the field of biotechnology, currently serving as a GMP Manufacturing Associate at CUTISS AG since June 2023. Prior experience includes a role as a Research Assistant at Kræftens Bekæmpelse from November 2022 to April 2023, and as a Master Thesis Student at the same organization from October 2021 to June 2022, where the focus was on melanoma phenotype switching and resistance to targeted therapies using in vitro murine and human models. Chiara also completed a Bachelor Thesis at UniTrento CIBIO in early 2020, utilizing an optimized CRISPR-Cas9 protocol to generate monoclonal lines with single-base mutations. Chiara holds a Master of Science in Cellular and Molecular Biotechnology from Università di Trento and a Bachelor's degree in Biomolecular Sciences and Technology from the same institution.
This person is not in any offices
CUTISS
CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDAOrphan drug designation for the treatment of burns.